Back to Agenda
SESSION 11 part 1: STATUS AND CHANGES IN RELATION TO CURRENT DISCLOSURE REQUIREMENTS IN EU AND THE USA
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
Speaker(s)
Update of EU Country Registries/Requirements
Tom Bosch, PhD
Netherlands
Director, Clinical Registry
EU PASS/PAES Requirements for Disclosure
Thomas Goedecke, PharmD, PhD
European Medicines Agency, Netherlands
Senior Pharmacovigilance Specialist
Have an account?